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Abstract
Introduction: Excessive alcohol consumption leads to unfavourable outcomes in people living with HIV (PLHIV), including
reduced adherence to antiretroviral therapy (ART) and engagement into care. However, there is limited information on alcohol
consumption patterns among PLHIV in sub-Saharan Africa.
Methods: Using a cross-sectional approach, the Alcohol Use Disorders Identification Test (AUDIT-C) was administered to
PLHIV attending HIV clinics in Co^te d’Ivoire, Togo, Senegal and Zambia (2013 to 2015). Hazardous drinking was defined as an
AUDIT-C score ≥4 for men or ≥3 for women, and binge drinking as ≥6 drinks at least once per month. The prevalence of
binge drinking was compared to estimates from the general population using data from the World Health Organization. Fac-
tors associated with binge drinking among persons declaring any alcohol use in the past year were assessed using a logistic
regression model to estimate odds ratio (OR) and their corresponding 95% confidence intervals (CI).
Results: Among 1824 PLHIV (median age 39 years, 62.8% female), the prevalence of hazardous alcohol use ranged from
0.9% in Senegal to 38.4% in Zambia. The prevalence of binge drinking ranged from 14.3% among drinkers in Senegal to 81.8%
in Zambia, with higher estimates among PLHIV than in the general population. Male sex (OR 2.4, 95% CI 1.6 to 3.7), tobacco
use (OR 1.7, 95% CI 1.0 to 2.9) and living in Zambia were associated with binge drinking.
Conclusions: Alcohol consumption patterns varied widely across settings and binge drinking was more frequent in HIV-posi-
tive individuals compared to the general population. Interventions to reduce excessive alcohol use are urgently needed to opti-
mize adherence in the era of universal ART.
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1 | INTRODUCTION
Sub-Saharan Africa (SSA) has the highest prevalence of HIV
globally, and accounts for 68% of people living with HIV
(PLHIV) [1]. Many countries in the region have high preva-
lence estimates of hazardous alcohol consumption, which has
been shown to be higher among PLHIV compared to the gen-
eral population [2]. Importantly, heavy episodic drinking, or
“binge drinking,” is common among young adults [3,4]. Specific
determinants of alcohol consumption vary widely across set-
tings as they are driven by a multitude of cultural, social,
financial and religious determinants [5]. As assessing and
addressing alcohol consumption have not been priorities in
routine HIV care in many clinical settings, knowledge about
this important comorbidity remains limited.
Excessive alcohol consumption leads to increased risk beha-
viour, notably condomless and coercive sex, which increase
levels of HIV transmission [6-8]. Furthermore, it also has neg-
ative implications for the health of PLHIV: it has been associ-
ated with low rates of antiretroviral therapy (ART) initiation,
poor engagement in medical care, virological failure and
reduced survival [9-11]. The negative impact of alcohol con-
sumption on ART adherence mediates many of these compli-
cations. In a study among US veterans, a dose–response
relationship between alcohol consumption and adherence was
found: periods of lower adherence often followed episodes of
alcohol consumption, and adherence decreased as levels of
alcohol consumption increased [12]. In SSA, alcohol consump-
tion has been recognized as one of the most important causes
of non-adherence to ART, especially in men [13]. Recent data
Nouaman MN et al. Journal of the International AIDS Society 2018, 21:e25202
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25202/full | https://doi.org/10.1002/jia2.25202
1
from a large randomized trial conducted in low- and middle-
income countries showed that binge drinking had a strong
impact on ART adherence, especially on weekends [14].
Importantly, living with HIV has been associated with addi-
tional risk factors of liver and cardiovascular disease in SSA,
including viral hepatitis B and C infections, and tobacco use. A
recent meta-analysis found a higher level of tobacco use
among HIV-positive persons from low- and middle-income
countries compared to negative ones [15]. However, there is
limited information on how HIV, tobacco and alcohol use
intersect in SSA.
Despite the recognized negative impact of excessive alcohol
consumption on the health status of PLHIV, the prevalence
and patterns of alcohol use among HIV-positive individuals
attending clinical care in SSA have not been widely described.
We aimed at evaluating alcohol consumption patterns among
PLHIV from four countries in West and Southern Africa. Fur-
thermore, we compared the prevalence of binge drinking
among the PLHIV participating in our study with estimates for
the corresponding general population.
2 | METHODS
2.1 | Study context and data sources
We performed a cross-sectional study of alcohol consumption
among HIV-positive patients attending care in four large
urban HIV clinics. In West Africa, 1050 PLHIV were enrolled
at referral hospitals in Abidjan, Co^te D’Ivoire (n = 350), Lome,
Togo (n = 350) and Dakar, Senegal (n = 350) between 2013
and 2015 [16]. In each clinic, a total of 10 to 15 patients were
randomly selected each day, during a period of three months.
In Lusaka, Zambia, 798 consecutive PLHIV were included at
the time of ART initiation between 2013 and 2014 [17]. All
sites were part of the International epidemiologic Databases
to Evaluate AIDS (IeDEA) network, a large international
cohort collaboration [18]. Data from Zambia, Senegal and
Togo were cleaned and merged with the existing database
from Abidjan, Co^te d’Ivoire. The study was approved by the
National Ethics Committees from Co^te d’Ivoire (no. 036/
MSLS/CNER-dkn), Togo (no. 117/MJRIR/SG/DAPR), Senegal
(no. 0178/MSAS/DPRS/CNERS), and by the ethics committees
of the University of Zambia (Lusaka, Zambia) and University
of Alabama at Birmingham (Birmingham, USA) for the Zam-
bian site. All patients signed an informed consent to partici-
pate in the study.
2.2 | Study measurements
Using a common protocol, we collected information on the fol-
lowing demographic, clinical and behavioural characteristics:
age, sex, marital status, education level, CD4 cell count, body
mass index, transaminases and ART history. Tobacco consump-
tion was reported as “never smoker” or “current or past smo-
ker.” Viral hepatitis infections were assessed using rapid
diagnostic tests: Determine (Alere, Waltham, MA, USA) for
hepatitis B surface antigen (HBsAg) and Oraquick (Orasure,
Bethlehem, PA, USA) for anti-hepatitis C virus (HCV) antibod-
ies, as these tests have shown relatively good diagnostic accu-
racy, including a validation study performed at our Zambian
study site [19,20].
2.3 | Assessment of alcohol consumption
In all sites, we assessed alcohol consumption using the abbrevi-
ated version of the Alcohol Use Disorders Identification Test
(AUDIT-C) questionnaire, which consists of three questions
focusing on the quantity and frequency of alcohol consumption
[21]. Nurses specifically trained for this purpose administered
the questionnaires. The three questions have five possible
answers, each of them giving between 0 and 4 points. Thus, the
maximum score is 12: score = 0 defines non-drinkers; a score
between 1 and 3 defines moderate drinkers; and a score above
3 (women) or 4 (men) defines hazardous drinking. Binge drink-
ing was defined based on the third question of the AUDIT-C
(≥6 drinks on one occasion at least monthly). Our research asso-
ciates were trained to convert alcoholic beverages consumed
on a typical day in number of standard drinks. Examples were
described on leaflets presenting the different kinds of drinks
(size and types) and what was considered as a standard unit of
alcohol intake (glass of wine of 14 cL, glass of beer of 25 cL,
glass of gin or locally brewed palm wine of 4 cL, etc.). In order
to contextualize binge drinking estimates from our study popu-
lation, we also describe estimates from the general population
using data from the Global Status Report on Alcohol and Health
2014 from the World Health Organization (WHO) [4]. These
are based on a wide range of sources in each country, including
published surveys, previous WHO-led surveillance studies and
alcohol sales data. According to WHO, a standard drink contains
13.5 g of alcohol. Binge drinking or heavy episodic drinking
would be defined as 60 or more grams of pure alcohol (on at
least one single occasion at least monthly), which is slightly
lower than the AUDIT-C-derived cut-off used to define binge
drinking in our study.
2.4 | Statistical analyses
We compared patient demographics and clinical characteristics
between countries using Student’s t-test, the non-parametric
Mann–Whitney U-test or analysis of variance for continuous
variables. We used the Pearson’s chi-square test or the Fish-
er’s exact test to compare frequencies. An unconditional logis-
tic model was used to identify factors associated with binge
drinking among participants reporting any alcohol use during
the past 12 months. Variables statistically associated with
binge drinking (p < 0.20) in univariable analyses were retained
and introduced into the initial multivariable model. A back-
ward stepwise regression procedure was applied to select the
final multivariate model. Adjusted odds ratios (aOR) were esti-
mated with their 95% confidence intervals (CI). A p < 0.05
was considered for statistical significance in the final model. In
sensitivity analyses, we evaluated the proportion of the whole
study population that reported binge drinking in each clinic,
and repeated the multivariable analyses in the full study
population. All analyses were performed with Stata software
(StataTM 12.0, College Station, TX, USA).
3 | RESULTS
3.1 | General characteristics
Of 1850 patients included in the database, 23 from West
Africa and three from Zambia had missing AUDIT-C scores
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and were excluded from the analyses. Data from 795 PLHIV
from Zambia and 1029 from West Africa were analysed. The
median age of the participants was 34 years (interquartile
range [IQR] 29 to 40) in Zambia versus 43 years (IQR 37 to
50) in West Africa (Table 1). In Zambia, women accounted for
53.7% of patients whereas 70.0% of the subjects were women
in West Africa. Participants from Senegal were less likely to
have access to schools (41.2%) compared to participants from
other countries. The proportion of patients reporting present
or past tobacco consumption was relatively high in Senegal
(26.5%) and Co^te d’Ivoire 61 (17.5%). In Togo, only 51.1% of
PLHIV were on ART, whereas this was the case for 96% of
them in Co^te d’Ivoire and Senegal, and 100% in Zambia. The
proportion of PLHIV with initial CD4 counts >200 cells/mm3
was highest in Zambia (54.6%) and lowest in Senegal (31.0%).
Overall, the prevalence of positive anti-HCV antibody was
0.8% (95% CI 0.4 to 1.2), and 10.6% (95% CI 9.2 to 12.1) had
a positive HBsAg test.
3.2 | Alcohol consumption among HIV-positive
individuals
Table 2 and Figure 1 show self-reported alcohol consumption
among 1824 HIV-positive patients across the four clinical
sites. A total of 685 participants (37.5%, 95% CI 35.3 to 39.8)
reported any alcohol consumption in the past year and the
overall prevalence of hazardous alcohol consumption was
21.7% (95% CI 19.8 to 23.5). Patients from Senegal were
more likely to report alcohol abstinence (91.5%), compared to
participants from other countries, where levels of abstinence
ranged from 53.6% in Co^te d’Ivoire to 59.4% in Togo. The
proportion of patients reporting hazardous alcohol
consumption was higher in Zambia (38.4%) than in Togo
(14.2%), Co^te d’Ivoire (10.6%) and Senegal (0.9%).The overall
prevalence of binge drinking was 1.2% in Senegal, 10.6% in
Co^te d’Ivoire, 17.9% in Togo and 36.2% in Zambia. Among
patients reporting any alcohol use in the past year, the esti-
mated prevalence of binge drinking ranged from 14.3% in
Senegal to 81.8% in Zambia. In all countries surveyed, haz-
ardous alcohol consumption and binge drinking were more
frequent among men compared to women (Table 2). Figure 2
describes estimates of binge drinking obtained in our study
and in the general population of each country.
3.3 | Risk factors of binge drinking
In multivariable analyses, male sex (aOR 2.4, 95% CI 1.6 to
3.7) and using tobacco (aOR 1.7, 95% CI 1.0 to 2.9) were
associated with binge drinking among patients having reported
any drinking (Table 3). Patients from Zambia were much more
likely to binge drink compared to those of other countries. In
analyses, including the full study population in each clinic, liv-
ing in Zambia, male sex and tobacco use remained significant
risk factors for binge drinking. In addition, age <35 years,
nadir CD4 count >200 cells/lL and HBsAg-positivity were sig-
nificant risk factors for binge drinking in the model including
drinkers as well as non-drinkers (Table S1).
4 | DISCUSSION
Across four large urban HIV clinics in West and Southern
Africa, hazardous alcohol consumption was reported by 13%
of women and 40% of men, whereas among drinkers, 41% of
Table 1. General characteristics of HIV-positive patients, by country
Co^te d’Ivoire
n = 349
Senegal
n = 328
Togo
n = 352
Zambia
n = 795 p
Male sex (%) 98 (28.1) 108 (32.9) 104 (29.5) 368 (46.3) <0.001
Marital status (%)
Never married 154 (44.1) 94 (28.7) 103 (29.3) 75 (9.5) <0.001
Divorced 89 (25.5) 1 (0.3) 2 (0.6) 145 (18.4)
Married 63 (18.1) 152 (46.3) 193 (55.0) 487 (61.9)
Widowed 43 (12.3) 81 (24.7) 53 (15.1) 80 (10.2)
Median age in years (IQR) 43 (38 to 50) 45 (39 to 53) 40 (33 to 48) 34 (29 to 40) 0.001
Education level (%)
None 74 (21.2) 135 (41.2) 53 (15.3) 46 (5.8) <0.001
Primary 71 (20.3) 79 (24.0) 110 (31.8) 136 (17.3)
Secondary 153 (43.8) 80 (24.4) 149 (43.1) 583 (74.2)
University 51 (14.6) 34 (10.4) 34 (9.8) 21 (2.7)
Median BMI (IQR) 23.5 (21 to 26.4) 21.5 (18.7 to 25) 22.7 (20.3 to 25.3) 20.3 (18.3 to 22.7) 0.001
Median CD4 count in cells/lL (IQR) 219 (82 to 352) 123 (47 to 234) 193 (91 to 296) 228 (118 to 337) 0.001
Tobacco consumption (%)
Never smokers 288 (82.5) 241 (73.5) 321 (91.7) 709 (89.2) <0.001
Present/past history of smoking 61 (17.5) 87 (26.5) 29 (8.3) 86 (10.8)
Positive HBs antigen (%) 35 (10.0) 40 (12.2) 21 (6.0) 98 (12.3) <0.001
Positive anti-HCV antibody (%) 1 (0.3) 6 (1.8) 7 (2.0) 1 (0.1) <0.001
BMI, body mass index; HCV, hepatitis C virus; IQR, interquartile range.
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Table 2. Prevalence of alcohol use, hazardous drinking and binge drinking according to participating country and gender
Co^te d’Ivoire
n = 349
Senegal
n = 328
Togo
n = 352
Zambia
n = 795
Total
n = 1824 p
AUDIT-C score: overall (%)
0 (non-drinker) 187 (53.6) 300 (91.5) 209 (59.4) 443 (55.7) 1139 (62.4) <0.001
1 to 3 (moderate drinker) 125 (35.8) 25 (7.6) 93 (26.4) 47 (5.9) 290 (15.9)
≥4 (hazardous drinker) 37 (10.6) 3 (0.9) 50 (14.2) 305 (38.4) 395 (21.7)
Binge drinking overall (%)a 37 (10.6) 4 (1.2) 63 (17.9) 288 (36.2) 392 (21.5) <0.001
Binge drinking among drinkers (%)a 37 (22.8) 4 (14.3) 63 (44.1) 288 (81.8) 392 (57.2) <0.001
AUDIT-C score: men (%)
0 (non-drinker) 49 (50.0) 94 (87.0) 43 (41.4) 140 (38.1) 326 (48.1) <0.001
1 to 3 (moderate drinker) 27 (27.5) 11 (10.2) 29 (27.9) 13 (3.5) 80 (11.8)
≥4 (hazardous drinker) 22 (22.5) 3 (2.8) 32 (30.7) 215 (58.4) 272 (40.1)
Binge drinking overall (%)a 21 (21.4) 2 (1.8) 37 (35.6) 196 (53.3) 256 (37.8) <0.001
Binge drinking among drinkers (%)a 21 (42.9) 2 (14.3) 37 (60.7) 196 (85.9) 256 (72.7) <0.001
AUDIT-C score: women (%)
0 (non-drinker) 138 (55.0) 206 (93.6) 166 (66.9) 303 (71.0) 813 (71.0) <0.001
1 to 2 (moderate drinker) 93 (37.1) 13 (5.9) 58 (23.4) 19 (4.4) 183 (16.0)
≥3 (hazardous drinker) 20 (7.9) 1 (0.5) 24 (9.7) 105 (24.6) 150 (13.0)
Binge drinking overall (%)a 16 (6.4) 2 (0.9) 26 (10.5) 92 (21.6) 136 (11.9) <0.001
Binge drinking among drinkers (%)a 16 (14.2) 2 (14.3) 26 (31.7) 92 (74.2) 136 (40.8) <0.001
aBinge drinking: ≥6 drinks on one occasion at least monthly (based on question no. 3 of AUDIT-C questionnaire).
Cote d’Ivoire
Alcohol use: 46.4%
Hazardous drinking: 10.6%
Binge drinking: 10.6%
Senegal
Alcohol use: 8.5% 
Hazardous drinking: 0.9%
Binge drinking: 1.2%
Togo
Alcohol use: 40.6%
Hazardous drinking: 14.2%
Binge drinking: 17.9%
Zambia
Alcohol use: 44.3%
Hazardous drinking: 38.4%
Binge drinking: 36.2%
Figure 1. Prevalence of reported current alcohol consumption, hazardous drinking and binge drinking in the past year among people living
with HIV in three clinics in West Africa and one in Southern Africa, according to the Alcohol Use Disorders Identification Test definition.
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women and 73% of men described episodes of binge drinking.
Compared with the general population of each country, the
prevalence of binge drinking was much higher in HIV-positive
individuals. Considering the impact of excessive alcohol con-
sumption on ART adherence and engagement into care, our
results highlight the need for a better understanding of the
determinants and risk factors of alcohol use for evaluating
interventions to reduce alcohol consumption among HIV-posi-
tive populations in SSA.
The systematic collection of data on alcohol consumption
patterns using the AUDIT-C score, a validated tool previously
used in African settings, among close to 2000 HIV-positive
patients allowed us to consider our robust estimates in the
light of published estimates from the general population of
each country. Among participants who reported any alcohol
consumption in the previous 12 months, 82% in Lusaka and
44% in Lome reported episodes of binge drinking. In the four
countries surveyed, we found a much higher prevalence of
binge drinking in HIV-positive patients compared to WHO
estimates among uninfected populations. The largest differ-
ence between populations was observed in Zambia, where
81.1% of PLHIV but only 7.2% of the general population
reported binge drinking. In Co^te d’Ivoire (22.8% in PLHIV and
10.4% in the general population) and Senegal (14.3% in PLHIV
and 3.4% in the general population), differences in prevalence
of binge drinking were moderate, whereas estimates from
both populations were more similar in Togo (44.1% in PLHIV
and 38.6% in the general population). Several recent studies
described high alcohol consumption levels among HIV-positive
individuals in SSA [22]. For instance, in a study of >3000 indi-
viduals recruited at inpatient and outpatients clinics in Kam-
pala, Uganda, individuals living with HIV were nearly twice as
likely to report current hazardous drinking as HIV-uninfected
participants [23]. Reasons for the increased alcohol consump-
tion among urban HIV-positive populations in SSA include
HIV-associated stigma, stress and depression, precarious
socio-economic situations and unemployment [24].
We found large differences in alcohol consumption patterns
across countries, potentially driven by contextual differences.
Hazardous alcohol consumption affected over 10% of the
study population in Zambia, Co^te d’Ivoire and Togo, but was
uncommon in Senegal (0.9% of participants), where the large
majority of the population is Muslim. We previously found sim-
ilar estimates in a study among 680 prison inmates in Senegal
and Togo: 12% of prisoners in Lome reported hazardous
drinking versus 5% in Senegal [25]. Similar differences in alco-
hol consumption patterns were found in Tanzania: alcohol con-
sumption was less common in adolescents of Muslim faith
compared to others, independent of the region where the sur-
vey was conducted [26].
In all cohorts included in our study, men were more likely
to show excessive alcohol consumption compared to women.
Among men who reported any alcohol consumption in the
previous 12 months, 86% in Lusaka and 61% in Lome
reported episodes of binge drinking. In analyses adjusted
for common confounders, men were three times more likely
to report binge drinking compared to women. These results
are consistent with findings from high-income countries,
where binge drinking, an increasing public health problem
among adolescents, is known to be more common among
men than women [27,28]. In these settings, long-term fol-
low-up studies have shown that binge-drinking male adoles-
cents frequently continue to do so and have a high risk of
chronic alcohol consumption in adulthood [29]. One excep-
tion in our study was the group of female participants from
Zambia, who also showed extremely high levels of binge
drinking (74%). However, the younger age of participants
from Zambia might have in part explained this result.
Although the long-term consequences of specific drinking
patterns have not been thoroughly assessed in individuals
living with HIV in SSA, the situation in Zambia, and, to a
lesser extent in West Africa, is worrisome and warrants
dedicated interventions to limit the detrimental effects of
alcohol in these populations.
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Figure 2. Prevalence of binge drinking among persons declaring any alcohol use in HIV-positive individuals and the general population, by
country.
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This is one of the first large studies focusing on the detailed
assessment of alcohol consumption patterns among HIV-posi-
tive individuals in SSA. The standardized evaluation of drinking
patterns as well as the collection of many potential risk fac-
tors using the same methodology across all sites allowed us
to make sound comparisons between countries. Unfortunately,
WHO does not express alcohol consumption based on
AUDIT-C criteria, but rather as the number of litres of pure
alcohol per year. Therefore, we were not able to compare haz-
ardous drinking between HIV-positive and uninfected persons
and the measures for binge drinking, although comparable,
were not identical. Although we gathered data from various
geographical areas, our study population, which we enrolled at
urban tertiary care clinics, was not representative of the HIV-
positive population in each country. Furthermore, the study
was restricted to three West African countries and one cohort
in Southern Africa, therefore limiting our ability to extrapolate
our findings to other countries in SSA. The self-reported nat-
ure of alcohol consumption is another limitation of our study,
as it may have led to reporting bias, especially in settings
where drinking is not socially acceptable. Thus, our estimates
as well as those from WHO, may have underestimated the
prevalence of excessive alcohol consumption, especially in set-
tings such as Muslim countries, where social desirability might
have played a role. Furthermore, it can be difficult to quantify
alcohol use in African settings where people drink traditional
alcoholic beverages with variable alcohol content, and use
nontraditional containers. Finally, the cross-sectional design of
our study did not allow the investigation of factors associated
with changing dynamics and patterns of alcohol consumption.
5 | CONCLUSIONS
Our study showed a very high prevalence of excessive alcohol
consumption among HIV-positive populations in four African
countries, and highlights the diversity in drinking patterns
across settings and subpopulations. Considering the dramatic
Table 3. Factors associated with binge drinking among HIV-positive patients reporting any alcohol use during the past 12 months
(n = 684)
Univariable analyses Multivariable analyses
n/N OR (95% CI) p OR (95% CI) p
Study site
Lusaka, Zambia 288/352 1 <0.001 1 0.001
Abidjan, Co^te d’Ivoire 37/162 0.07 (0.04 to 0.1) 0.07 (0.04 to 0.1)
Dakar, Senegal 4/28 0.04 (0.01 to 0.1) 0.03 (0.01 to 0.08)
Lome, Togo 63/143 0.2 (0.1 to 0.3) 0.2 (0.1 to 0.3)
Sex
Female 136/333 1 <0.001 1 0.001
Male 256/352 4.0 (2.8 to 5.6) 2.4 (1.6 to 3.7)
Age in years
≥35 216/426 1 <0.001 1 0.9
<35 176/259 2.1 (1.5 to 2.8) 0.9 (0.6 to 1.5)
Marital status (n = 682)
Never married 68/167 1 0.002
Divorced 64/105 2.3 (1.4 to 3.7)
Married 230/338 3.1 (2.1 to 4.5)
Widowed 28/72 0.9 (0.5 to 1.6)
Education level (n = 680)
None 25/58 1 0.001
Primary 67/132 1.4 (0.7 to 2.5)
Secondary 268/422 2.3 (1.3 to 4.0)
University 29/68 0.9 (0.5 to 1.9)
Tobacco consumption
Never smokers 291/532 1 0.01 1 0.03
Present/past history of smoking 101/152 1.6 (1.1 to 2.4) 1.7 (1.04 to 2.9)
HBs antigen
Negative 337/600 1 0.13
Positive 55/85 1.4 (0.9 to 2.3)
Nadir CD4 count in cells/lL
≤200 39/135 1 <0.001
>200 353/550 4.4 (2.9 to 6.6)
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impact of alcohol use disorder on health-related issues but
also on families and society as a whole, it is urgent to consider
this issue as a public health threat in SSA. Hopefully, the
results of our study will help inform the design and implemen-
tation of tailored interventions to prevent and/or reduce alco-
hol consumption among PLHIV in Africa. Behavioural
interventions focusing on alcohol use reduction showed posi-
tive results in PLHIV [30]. However, interventions such as
motivational interviewing have been poorly studied in SSA to
date and deserve more attention [31]. Considering the poten-
tial impact of excessive alcohol consumption on adherence to
ART and HIV care, addressing this issue might prove useful
for the success of the “treat all” ART strategy which is being
rolled-out across SSA.
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